Bidding Closed for this Notice
The submission deadline for this tender passed on Nov 04, 2026. This opportunity is archived for historical reference.
Price Registration, for a period of 1 year, which may be extended for the same period, as long as the advantageous price is proven, for future and eventual acquisition of MEDICINES CEAF 06
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
Price Registration, for a period of 1 year, which may be extended for the same period, as long as the advantageous price is proven, for future and eventual acquisition of MEDICINES CEAF 06 (L1):CLOBAZAM, 20 MG, (L2):ELTROMBOPAG OLAMIN, 25 MG, (L3):ALFAEPOETIN, 1,000 I.U., (L4): ALFAEPOETIN, 2,000 IU, (L5): ALFAEPOETIN, 3,000 I.U., (L6):EVEROLIMO, 0.75 MG, (L7):METHOTREXATE, 25 MG/ML, (L8):OLANZAPINE, 10 MG, (L9):QUETIAPINE, FUMARATE, 300 MG
Related Procurement Opportunities
Similar tenders in Pharmaceuticals